Status:
NOT_YET_RECRUITING
Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.
Lead Sponsor:
Sohag University
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease with multiple clinical presentations or phenotypes and remains a highly prevalent condition, causing significant mor...
Eligibility Criteria
Inclusion
- chronic respiratory symptom and signs such as cough ,breathlessness , wheeze ; forced expiratory volume in one second(FEV1)of predicted (FEV1%) less than 80 % ; the ratio of FEV1 to forced vital capacity (FVC , FEV1/ FVC)\<70 % ; FEV1reversibility after inhalation of 200g salbutamol (bronchodilator) of less than 12 % of prebronchodilator FEV1.
Exclusion
- Coexistence of asthma and COPD or with earlier history of bronchial asthma as well as patients who have never smoked were excluded from the study.
- \-
Key Trial Info
Start Date :
October 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 24 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06503315
Start Date
October 30 2024
End Date
February 24 2026
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt